Castle Biosciences Inc (CSTL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.06B
EV to revenue ratio (TTM)
2.18
EV to ebitda
12.47
Financial Performance
Revenue (TTM)
$0.38B
Gross profit (TTM)
$0.29B
EBITDA
-$0.01B
Profitability
Operating margin (TTM)
-2.65%
Profit margin
-6.10%
Return on assets (TTM)
-3.07%
Return on equity (TTM)
-4.87%
Per Share Metrics
Revenue per share (TTM)
$12.61
EPS
-$0.76
Diluted EPS (TTM)
-$0.76
Book value
$15.55
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
2.81
Price to book ratio (TTM)
2.22
Growth
Quarterly earnings growth (YoY)
23.90%
Quarterly revenue growth (YoY)
-51.60%
Analyst Sentiment
Strong buy
0
Buy
10
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.95